Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (201-210 of 392) with videos related to

Pageof 40
Sort By:
Leukemia|December 25, 2009
CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2AD N Eissens, N P M Schaap, F W M B Preijers, et al.
Cell Death & Disease|July 6, 2013
Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsT Kohl, N Gehrke, A Schad, et al.
Critical Care Medicine|July 1, 1985
Predictors of myocardial infarction in emergency room patientsW M Tierney, B J Roth, B Psaty, et al.
International Journal of Cardiology|August 6, 2018
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionFrank P Schmidt, Tim Zimmermann, Till Wenz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Medicine|December 17, 2021
Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United StatesLeonardo Ruiz-Casas, Gabriel Pedra, Anum Shaikh, et al.
Annals of Hepatology|December 4, 2024
A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD studyJeffrey V Lazarus, William Alazawi, Ron Basuroy, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Journal of Hepatology|July 13, 2016
Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factorsNadine Gehrke, Marcus A Wörns, Yvonne Huber, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Pageof 40

Showing results (201-210 of 392) with videos related to

Sort By:
Pageof 40
Leukemia|December 25, 2009
CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2AD N Eissens, N P M Schaap, F W M B Preijers, et al.
Cell Death & Disease|July 6, 2013
Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsT Kohl, N Gehrke, A Schad, et al.
Critical Care Medicine|July 1, 1985
Predictors of myocardial infarction in emergency room patientsW M Tierney, B J Roth, B Psaty, et al.
International Journal of Cardiology|August 6, 2018
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionFrank P Schmidt, Tim Zimmermann, Till Wenz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Medicine|December 17, 2021
Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United StatesLeonardo Ruiz-Casas, Gabriel Pedra, Anum Shaikh, et al.
Annals of Hepatology|December 4, 2024
A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD studyJeffrey V Lazarus, William Alazawi, Ron Basuroy, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Journal of Hepatology|July 13, 2016
Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factorsNadine Gehrke, Marcus A Wörns, Yvonne Huber, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Pageof 40